Senior Principal Scientist
Bristol-Myers Squibb
Ewing, New Jersey
SURENDRAN RAJENDRAN
Senior Principal Scientist
Bristol-Myers Squibb
Surendran.rajendran@bms.com
Education:
• University of Texas Medical Branch, Galveston, TX, USA, Post Doctorate
• Ph. D - University of Mysore, CFTRI, India, Doctorate
• Publications: Manuscript Publications: 40
Bristol-Myers Squibb
• PK, PD, Biomarker bioanalytical support to Discovery biologics programs
• DoE strategies for Ligand Binding Assay (LBA) and DoE Automation
• Methods for AAV Empty / Full capsid ratio in buffer, biological matrices
• Tissue PK, PD Immuno-analysis: Tissue bioanalysis DoE (Oral presentation at AAPS), Biopsy analysis: Adaptive Focused Acoustics (AFA)
• New immuno-analytical platforms development
• Universal Immunoassay for PEG (Poster presentation at AAPS)
Amgen
• Thermodynamic method for tight binding interactions - biologic drug candidate selection tool
• DBS, DMS of biologics for PK & TK studies (Oral presentation at AAPS)
• High throughput binding affinity determination by GYROS
University of Texas Medical Branch
• Cell / LC based methodology: HIV and HCV polymerase inhibitors’ metabolic fate elucidation
• Kinetic mechanism for E. coli DnaB helicase ATPase activity
• Tubule formation mechanism by HIV Rev
• Purification, biochemical, biophysical characterization: Human, Rat repair polymerase beta, anti-HCV drug Locteron, oil seed proteins (sesame α, β globulins), phytate interaction, safflower carmin self-association
Disclosure information not submitted.
Personalizing Clinical Immunogenicity Risk Through HLA DR Alleles Associations
Wednesday, May 15, 2024
9:30 AM – 10:00 AM PT